NASDAQ · GBNH
Healthcare · Medical - Care Facilities
$0.12
Down-$0.08 (-40.69%)
Updated Aug 15, 2026, 1:08 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
GBNH does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning GBNH.
GBNH research
Company profile and research snapshot.
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 19, 2023 | Lake Street | Buy | — |
| Apr 19, 2023 | Canaccord Genuity | Hold | — |
No generated briefing is available yet.
Zacks Investment Research · Aug 9, 2023
LifeStance Health (LFST) delivered earnings and revenue surprises of -44.44% and 1.93%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Jul 26, 2023
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 3.14% and 4.22%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Nov 9, 2022
Greenbrook TMS Inc. (GBNH) delivered earnings and revenue surprises of -131.82% and 14.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Nov 7, 2022
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -22.22% and 2.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning GBNH.
No results
No recent SID articles mention GBNH.
